Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv in Children with ADHD and Oppositional Symptoms
NCT00367835Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Dec 2006; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00367835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367835.